Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

Updates to the medical benefit specialty drug cost-sharing list

May 31, 2018

Effective July 1, 2018, Independence will update its list of specialty drugs that require member cost-sharing (i.e., copayment, deductible, and coinsurance). Cost-sharing applies to select medical benefit specialty drugs for members who are enrolled in Commercial FLEX products and other select plans. The member's cost-sharing amount is based on the terms of the member's benefit contract. In accordance with your Provider Agreement, it is the provider?s responsibility to verify a member?s individual benefits and cost-sharing amounts.

The list has been expanded to include approximately 155 drugs, including additions for the following drugs:

  • Crysvita® (burosumab-twza)
  • IlumyaTM (tildrakizumab-asmn)
  • TrogarzoTM (ibalizumab-uiyk)
  • Eculizumab biosimilar
The comprehensive list of specialty drugs with cost-sharing is now available on our website.


This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.